Shop
-1.png)
eStoreRx™
Online Supplement Dispensary
eStoreRx™ is an easy direct-to-patient ordering & fulfilment program for lifelong wellness.
For over 40 years, Biotics Research Corporation has revolutionized the nutritional supplement industry by utilizing “The Best of Science and Nature”. Combining nature’s principles with scientific ingenuity, our products magnify the nutritional
eStoreRx™ is an easy direct-to-patient ordering & fulfilment program for lifelong wellness.
Biotics Research is proud to expand our commitment to education with the Wellness Unfiltered Pro Podcast. Each episode delves into key health topics and the clinical applications of our premier products. Through candid, insightful conversations, our team offers practical guidance to keep you informed and empowered as a healthcare professional.
July 17 2025
After over a half century of public health advice warning against diets high in saturated fat, the finger is starting to point toward oils rich in pol...
Results of a longitudinal observational cohort study were recently published in European Urology Oncology, describing the association between multivitamin use and the recurrence of prostate cancer. This study included nearly 1400 men with nonmetastatic cancer who underwent radical prostatectomy or radiation therapy and were enrolled in the Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE) study. The primary outcome was prostate cancer recurrence.
Sixty-two percent of the men were current multivitamin (MV) users, compared to 16% past MV users and 22% never users. Among the men currently taking an MV, there was a 49% lower risk for recurrence over a median follow-up of nearly 5 years, adjusted for other variables (such as smoking, age, etc.). A stratified analysis found that the apparent reduction in recurrence risk was even stronger among men with a more aggressive cancer (grade 2, Gleason 3+4, or greater), in which the risk for recurrence was 73% lower. Among men with grade 1 (Gleason 3+3), the association was no longer significant.
While this was not a controlled trial, it is the first to suggest a benefit of multivitamin use for men diagnosed with prostate cancer, at least those with grade 2 or higher. A large controlled trial (Physician’s Health Study II) did not find a significant difference in the initial incidence of prostate cancer among men taking multivitamins compared to placebo, though there was an overall reduction in cancer risk. An observational study published in 2024 did not find a survival benefit with multivitamin use for men with prostate cancer, though it was also not a controlled trial.
Submit this form and you'll receive our latest news and updates.
Results of one of the few existing long-term randomized trials evaluating the use of multivitamins on cognitive function...
Learn more
*These statements have not been evaluated by the Food and Drug Administration. This product has not intended to diagnose, treat, cure, or prevent any disease.
Proposition 65 Warning
© 2025 Biotics Research Corporation - All Rights Reserved
Submit your comment